Dose ranges reflect commonly studied amounts in published research models. This is not medical advice. For research use only. Not for human consumption.
Protocol Comparison
Skin & Hair
Research dose range
Standard research range
1 - 2 mg
The working range — where most protocols actually live for general skin and tissue support.
Research focus
Collagen synthesis / tissue regeneration
Observed window
4-8 weeks
Administration
Daily
Primary pathway
Collagen/ECM remodeling, VEGF, Antioxidant defense
Mechanism reference: Pickart & Margolina, Int J Mol Sci, 2018. Injectable dosing reflects community protocol, not a dedicated clinical trial. For research use only.
PROTOCOL BENEFITS
◆
Triggers collagen and elastin synthesis — rebuilding skin structure at the cellular level.
◆
Accelerates wound healing and tissue repair — one of the most extensively studied regenerative peptides in the field.
◆
Antioxidant activity that protects skin cells from oxidative stress, the process most directly tied to visible aging.
SCIENCE
GHK-Cu is a naturally occurring copper peptide found in human plasma — one whose concentration drops significantly with age. It works by activating genes tied to tissue repair, collagen production, and cellular regeneration, effectively signaling skin biology back toward a younger operating state.
The gene-expression research behind this is well-documented (Pickart & Margolina, Int J Mol Sci, 2018) — GHK-Cu influences hundreds of genes associated with tissue remodeling and repair. Injectable use follows community protocol rather than a dedicated clinical trial, but the underlying biology is some of the best-characterized in the regenerative peptide space.
WHAT TO EXPECT
Skin texture and firmness improvements are typically observed within 4-8 weeks. Wound-healing benefits may appear sooner, depending on the protocol.
PROTOCOL NOTE
Available in 50mg and 100mg. For research use only. Full documentation included with every order.
FAQ
Injectable delivery bypasses skin absorption limits entirely — the compound reaches circulation directly rather than depending on how much a topical formulation can push through the skin barrier.
Most protocols run 8 weeks on, 8 weeks off — copper handling is generally what sets that ceiling.
